skip to Main Content

Functional Assays

See table below for our current offerings.
Assay Type Antigen Model Details
Hemagglutinin Inhibition Assay H1N1, H3N2, H5N1, H7N9, H10N8
Hemolytic Toxin Neutralization Assay Alpha hemolysin
Non-canonical leukocidin pairs
Leukocidin Toxin Neutralization Assay PVL Luk S/Luk F
Luk ED
Hlg AB
Hlg CB
Superantigen Toxin Neutralization Assay Staphylococcal Enterotoxin A
Staphylococcal Enterotoxin B
Staphylococcal Enterotoxin C
Filovirus GP VSV-pseudotyped Assay Ebola
Back To Top
×Close search
Fig. 1 Survival after challenge with INFV H1N1 A/Pert/261/2009 (Tamiflu-resistant strain). Inoculum 1xLD90=1.0E+05 PFU/mouse
Survival after challenge with INFV H1N1 A/Pert/261/2009 (Tamiflu-resistant strain) 1.0E+05 PFU/mouse
Survival and weight change in BALB/c mice challenged with INFV A/ Texas/36/91 (H1N1) and treated with antiviral Osletamivir Phosphate (Tamiflu)
Lung viral load and Survival (30 % weight loss cut-off) in BALB/c mice challenged with INFV H3N2 A/HK/1/68.

Alpha (UK) – B. 1.1.7 / 501Y.V1

amino acid mutations: del69–70 HV, del144 Y, N501Y, A570D, D614G, P681H, T761I, S982A, D1118H

Beta (South Africa) – B.1.351

amino acid mutations: K417N, E484K, N501Y, D614G, A701V

Gamma (Brazil) – P.1

amino acid mutations: L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I

Epsilon (Ca, USA) B.1.427

amino acid mutations: L452R, D614G

SARS-CoV-2 Parental Strain Wild Type (Wuhan)
SARS-CoV-2 D614G Variant

amino acid mutations: D614G

Epsilon (Ca, USA) B.1.429

amino acid mutations: S13I, W152C, L452R, D614G

SARS-CoV-2 Delta Variant

amino acid mutations: L452R, E484Q